• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Separation of receptor-binding and profusogenic domains of glycoprotein D of herpes simplex virus 1 into distinct interacting proteins.将单纯疱疹病毒1型糖蛋白D的受体结合结构域和促融合结构域分离为不同的相互作用蛋白。
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4142-6. doi: 10.1073/pnas.0611565104. Epub 2007 Feb 27.
2
The pro-fusion domain of herpes simplex virus glycoprotein D (gD) interacts with the gD N terminus and is displaced by soluble forms of viral receptors.单纯疱疹病毒糖蛋白D(gD)的融合前结构域与gD的N末端相互作用,并被病毒受体的可溶性形式所取代。
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9323-8. doi: 10.1073/pnas.0503907102. Epub 2005 Jun 21.
3
Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor.表现出尿激酶型纤溶酶原激活剂氨基末端片段的单纯疱疹病毒1重组病毒粒子可通过同源受体进入细胞。
Gene Ther. 2006 Apr;13(7):621-9. doi: 10.1038/sj.gt.3302685.
4
Use of chimeric nectin-1(HveC)-related receptors to demonstrate that ability to bind alphaherpesvirus gD is not necessarily sufficient for viral entry.利用嵌合的nectin-1(HveC)相关受体来证明,与α疱疹病毒gD结合的能力不一定足以实现病毒进入。
Virology. 2001 Jul 5;285(2):366-75. doi: 10.1006/viro.2001.0989.
5
Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities.单纯疱疹病毒1型、伪狂犬病病毒和牛疱疹病毒1型中的糖蛋白D同源物以不同亲和力直接与人HveC(nectin-1)结合。
Virology. 2001 Feb 1;280(1):7-18. doi: 10.1006/viro.2000.0747.
6
The domains of glycoprotein D required to block apoptosis induced by herpes simplex virus 1 are largely distinct from those involved in cell-cell fusion and binding to nectin1.单纯疱疹病毒1诱导的细胞凋亡阻断所需的糖蛋白D结构域与细胞间融合及与nectin1结合所涉及的结构域在很大程度上是不同的。
J Virol. 2003 Mar;77(6):3759-67. doi: 10.1128/jvi.77.6.3759-3767.2003.
7
Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.基于结构的单纯疱疹病毒糖蛋白D诱变确定了gD-HveA/HVEM结合界面的三个关键区域。
J Virol. 2003 Jul;77(14):8127-40. doi: 10.1128/jvi.77.14.8127-8140.2003.
8
Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM).基于结构的单纯疱疹病毒糖蛋白D结合位点分析,该位点存在于疱疹病毒进入介质HveA(HVEM)上。
J Virol. 2002 Nov;76(21):10894-904. doi: 10.1128/jvi.76.21.10894-10904.2002.
9
Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry.单纯疱疹病毒糖蛋白D可与脊髓灰质炎病毒受体相关蛋白1或疱疹病毒进入介质结合,这两种病毒进入介质在结构上不相关。
J Virol. 1998 Sep;72(9):7064-74. doi: 10.1128/JVI.72.9.7064-7074.1998.
10
Localization of the gD-binding region of the human herpes simplex virus receptor, HveA.人类单纯疱疹病毒受体HveA的gD结合区域的定位
J Virol. 2001 Jan;75(1):171-80. doi: 10.1128/JVI.75.1.171-180.2001.

引用本文的文献

1
Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors.用于靶向治疗携带表皮生长因子受体(EGFR)肿瘤的溶瘤单纯疱疹病毒。
Mol Ther Oncol. 2024 Jan 10;32(1):200761. doi: 10.1016/j.omton.2024.200761. eCollection 2024 Mar 21.
2
Targeted Delivery of IL-12 Adjuvants Immunotherapy by Oncolytic Viruses.溶瘤病毒靶向递送 IL-12 佐剂免疫疗法。
Adv Exp Med Biol. 2021;1290:67-80. doi: 10.1007/978-3-030-55617-4_4.
3
Entry of Alphaherpesviruses.α疱疹病毒的进入。
Curr Issues Mol Biol. 2021;41:63-124. doi: 10.21775/cimb.041.063. Epub 2020 Aug 7.
4
Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins.通过工程病毒包膜糖蛋白实现溶瘤单纯疱疹病毒的肿瘤靶向和中和逃逸。
Drug Deliv. 2018 Nov;25(1):1950-1962. doi: 10.1080/10717544.2018.1534895.
5
Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells.溶瘤单纯疱疹病毒gB和gD中的双配体插入,用于重新靶向到生产性Vero细胞系和癌细胞。
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.02122-17. Print 2018 Mar 15.
6
Simultaneous Insertion of Two Ligands in gD for Cultivation of Oncolytic Herpes Simplex Viruses in Noncancer Cells and Retargeting to Cancer Receptors.在gD中同时插入两种配体以实现在非癌细胞中培养溶瘤单纯疱疹病毒并重新靶向癌症受体。
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.02132-17. Print 2018 Mar 15.
7
Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage.定位单纯疱疹病毒 1 型糖蛋白 D 的插入位点并影响 gD 和 gB 受体的使用。
Sci Rep. 2017 Mar 3;7:43712. doi: 10.1038/srep43712.
8
A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.一种在非癌细胞中培养重定向溶瘤单纯疱疹病毒的策略。
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.00067-17. Print 2017 May 15.
9
Retargeting of herpes simplex virus (HSV) vectors.单纯疱疹病毒(HSV)载体的重新靶向
Curr Opin Virol. 2016 Dec;21:93-101. doi: 10.1016/j.coviro.2016.08.007. Epub 2016 Sep 8.
10
Oncolytic virotherapy using herpes simplex virus: how far have we come?使用单纯疱疹病毒的溶瘤病毒疗法:我们进展到了什么程度?
Oncolytic Virother. 2015 Nov 25;4:207-19. doi: 10.2147/OV.S66086. eCollection 2015.

本文引用的文献

1
Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13alpha2 receptor.一种设计为仅通过白细胞介素-13α2受体进入细胞的单纯疱疹病毒1型的构建及特性
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5508-13. doi: 10.1073/pnas.0601258103. Epub 2006 Mar 22.
2
Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor.表现出尿激酶型纤溶酶原激活剂氨基末端片段的单纯疱疹病毒1重组病毒粒子可通过同源受体进入细胞。
Gene Ther. 2006 Apr;13(7):621-9. doi: 10.1038/sj.gt.3302685.
3
Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry.未结合配体的单纯疱疹病毒gD结构揭示了受体介导的病毒进入激活机制。
EMBO J. 2005 Dec 7;24(23):4144-53. doi: 10.1038/sj.emboj.7600875. Epub 2005 Nov 17.
4
The pro-fusion domain of herpes simplex virus glycoprotein D (gD) interacts with the gD N terminus and is displaced by soluble forms of viral receptors.单纯疱疹病毒糖蛋白D(gD)的融合前结构域与gD的N末端相互作用,并被病毒受体的可溶性形式所取代。
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9323-8. doi: 10.1073/pnas.0503907102. Epub 2005 Jun 21.
5
A heptad repeat in herpes simplex virus 1 gH, located downstream of the alpha-helix with attributes of a fusion peptide, is critical for virus entry and fusion.单纯疱疹病毒1型糖蛋白H(gH)中一个七肽重复序列位于具有融合肽特性的α-螺旋下游,对病毒进入和融合至关重要。
J Virol. 2005 Jun;79(11):7042-9. doi: 10.1128/JVI.79.11.7042-7049.2005.
6
Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells.一种经设计可通过恶性胶质瘤细胞的IL13Rα2受体进入细胞的重组单纯疱疹病毒1型的特性分析
J Virol. 2005 May;79(9):5272-7. doi: 10.1128/JVI.79.9.5272-5277.2005.
7
Potential nectin-1 binding site on herpes simplex virus glycoprotein d.单纯疱疹病毒糖蛋白d上潜在的nectin-1结合位点。
J Virol. 2005 Jan;79(2):1282-95. doi: 10.1128/JVI.79.2.1282-1295.2005.
8
Random mutagenesis of the gene encoding a viral ligand for multiple cell entry receptors to obtain viral mutants altered for receptor usage.对编码用于多种细胞进入受体的病毒配体的基因进行随机诱变,以获得受体使用情况发生改变的病毒突变体。
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17252-7. doi: 10.1073/pnas.0407892101. Epub 2004 Nov 22.
9
Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism.单纯疱疹病毒糖蛋白D中的突变可阻止通过连接蛋白进入细胞并改变细胞嗜性。
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12414-21. doi: 10.1073/pnas.0404211101. Epub 2004 Jul 23.
10
The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry.单纯疱疹病毒gD的可溶性胞外域包含一个膜近端融合前结构域,足以介导病毒进入。
Proc Natl Acad Sci U S A. 2004 May 11;101(19):7445-50. doi: 10.1073/pnas.0401883101. Epub 2004 May 3.

将单纯疱疹病毒1型糖蛋白D的受体结合结构域和促融合结构域分离为不同的相互作用蛋白。

Separation of receptor-binding and profusogenic domains of glycoprotein D of herpes simplex virus 1 into distinct interacting proteins.

作者信息

Zhou Guoying, Roizman Bernard

机构信息

The Marjorie B. Kovler Viral Oncology Laboratories, University of Chicago, 910 East 58th Street, Chicago, IL 60637, USA.

出版信息

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4142-6. doi: 10.1073/pnas.0611565104. Epub 2007 Feb 27.

DOI:10.1073/pnas.0611565104
PMID:17360490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1820722/
Abstract

The 369-residue glycoprotein D (gD) is the entry, receptor-binding protein of herpes simplex virus 1. The common receptors for viral entry are nectin-1, HveA, and a specific O-linked sulfated proteoglycan. The major receptor-binding sites of gD are at the N terminus, whereas the domain required for fusion of viral envelope with the plasma membrane is at the C terminus of the ectodomain (residues 260-310). In the course of retargeting gD to the urokinase plasminogen activator (uPA) receptor for potential therapeutic applications, we obtained a genetically engineered infectious virus in which the receptor-binding domain consisting of the N-terminal domain of uPA fused to residues 33-60 of gD was separated from an independently expressed C-terminal domain of gD containing residues 219-369. The intervening sequences (residues 62-218) were replaced by a stop codon and a promoter for the C-terminal domain of gD. The physical interaction of the two components was reconstructed by coimmunoprecipitation of the N-terminal domain of uPA with the C-terminal domain of gD. These results indicate that codons 61-218 of gD do not encode executable functions required for viral entry into cells and suggest that the receptor-binding ligand must interact with but need not alter the structure of the residual portion of gD to effect virus entry. This finding opens the way for the development of a family of recombinant viruses in which the profusion domain of gD and independently furnished, interacting receptor-binding domains effect entry of the virus via a range of receptors.

摘要

由369个氨基酸残基组成的糖蛋白D(gD)是单纯疱疹病毒1型的进入和受体结合蛋白。病毒进入细胞的常见受体是nectin-1、HveA和一种特定的O-连接硫酸化蛋白聚糖。gD的主要受体结合位点位于N端,而病毒包膜与质膜融合所需的结构域位于胞外结构域的C端(第260 - 310位氨基酸残基)。在将gD重新靶向尿激酶型纤溶酶原激活剂(uPA)受体以用于潜在治疗应用的过程中,我们获得了一种基因工程感染性病毒,其中由uPA的N端结构域与gD的第33 - 60位氨基酸残基融合而成的受体结合结构域与独立表达的包含第219 - 369位氨基酸残基的gD C端结构域分离。中间序列(第62 - 218位氨基酸残基)被一个终止密码子和gD C端结构域的启动子取代。通过uPA的N端结构域与gD的C端结构域的共免疫沉淀重建了这两个组分的物理相互作用。这些结果表明,gD的第61 - 218位密码子不编码病毒进入细胞所需的可执行功能,并表明受体结合配体必须与gD的剩余部分相互作用,但无需改变其结构即可实现病毒进入。这一发现为开发一系列重组病毒开辟了道路,在这些重组病毒中,gD的融合结构域和独立提供的相互作用受体结合结构域通过一系列受体实现病毒的进入。